‘Off-the-Shelf’ Immunotherapy Gets Special Treatment in Special Issue of The Journal Cells
Thanks go to Special Editor, Cartherics CEO Alan Trounson
By Leigh Dayton, 17 January 2022
Cellular immunotherapy is revolutionizing cancer treatment, and off-the-shelf or allogeneic, treatments are beginning to replace technologies developed individually for each patient.
This is good news because the potential of allogeneic therapies is great. They promise to significantly save time and cut costs compared […]